Shares of Wave Life Sciences Ltd. (WVE) are down over 55% from their 52-week high of $56 recorded on September 24, 2018.
Mountain View, California-based IGM Biosciences is a biotechnology company developing engineered IgM antibodies for the treatment of cancer patients.
Immunoglobulin M (IgM) is a class of antibody naturally produced by the human immune system.
The end of the third quarter is fast approaching. The third quarter IPO activity in the U.S. pharma/biotech sector has been somewhat tepid with around 9 listings so far in the quarter.
InMode Ltd. (INMD), which is developing devices that use minimally invasive radio-frequency technology for aesthetic medical procedures, has been hitting new highs.
Shares of Ardelyx Inc. (ARDX) closed at a new 52-week high of $5.82 yesterday, a gain of over 70% in one day, thanks to the second positive hyperphosphatemia study, dubbed AMPLIFY.
Shares of Apellis Pharmaceuticals Inc. (APLS), which touched an all-time high of $30.25 in intraday trading yesterday, are up 132 percent year-to-date.
Shares of French biotechnology company Abivax SA (ABVX.PA), which hit a 52-week low of EUR 5.20 on October 26, 2018, have since gained 64 percent.
NovoCure Ltd. (NVCR) has come a long way this year, and the shares are up an impressive 178 percent year-to-date.
Shares of Orchard Therapeutics plc (ORTX) are down 11 percent year-to-date while the iShares Nasdaq Biotechnology ETF (IBB), a bellwether of investor sentiment, has gained 8 percent for the same period.
Shares of Neurotrope Inc. (NTRP) are down nearly 53 percent from their 52-week high of $10.50 recorded on August 9, 2018. Will the third quarter be a thing to remember for Neurotrope?
In the healthcare sector, 6 companies made their debut on the NASDAQ last month. Let's take a look at what's in store on the U.S. healthcare IPOs scheduled for the week ahead.
Shares of Hologic Inc. (HOLX), which touched a 52-week high of $50.43 in intraday trading yesterday, are up 30 percent year-to-date.
Shares of Alphatec Holdings Inc. (ATEC), which touched a 52-week high of $5.24 in intraday trading on Thursday (July 25, 2019), are up more than 123 percent year-to-date.
As another week comes to a close, it is time to take a look at the U.S. healthcare IPOs scheduled for the week ahead.
Shares of Galapagos NV (GLPG), which touched an all-time high of $174.63 in intraday trading on Monday, have gained 90 percent year-to-date. GLPG was trading around $55 when we alerted our premium subscribers to this stock on July 17, 2015.